Genome-level therapeutic targets identification and chimeric Vaccine designing against the Blastomyces dermatitidis.
Ontology highlight
ABSTRACT: Blastomyces dermatitidis is a thermally dimorphic fungus that can cause serious and sometimes fatal infections, including blastomycosis. After spore inhalation, a pulmonary infection develops, which can be asymptomatic and have lethal effects, such as acute respiratory distress syndrome. Its most common extra-pulmonary sites are the central nervous system, bones, skin, and genito-urinary systems. Currently, no vaccine has been approved by the FDA to prevent this infection. In the study, a peptide-based vaccine was developed against blastomycosis by using subtractive proteomics and reverse vaccinology approaches. It focuses on mining the whole genome of B. dermatitidis, identifying potential therapeutic targets, and pinpointing potential epitopes for both B- and T-cells that are immunogenic
SUBMITTER: Mursaleen S
PROVIDER: S-EPMC11367477 | biostudies-literature | 2024 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA